Company · sysnav-77702043
SYSNAV
4 sourcescompanies-2026-11-14-0.1.0
Cite this record
ConductScience Library. SYSNAV. Companies, record sysnav-77702043. Release companies-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/companies/sysnav-77702043
On this page
Company
The name as ClinicalTrials.gov gives it. A company is a name ClinicalTrials.gov classes as industry, and spellings that differ only in case or spacing are one; no subsidiary is folded into a parent. A trial of two phases counts in both, and recruiting trials count as active.
- Name
- SYSNAV
- Trials
- 23
- As lead sponsor
- 5
- As collaborator
- 18
- Recruiting
- 12
- Active, recruiting or not
- 17
- Completed
- 4
- Stopped early, withdrawn or suspended
- 1
- Posted results
- 1
- Trials by phase
- Phase 1 1, Phase 2 2
- Drugs its trials test
- 2
- Comparisons calculated in its trials
- 0
- First trial registered
- 2014-12-08
- Last update
- 2026-10-26
Source ClinicalTrials.gov
Pipeline2
The drugs its trials test, by the trial links the pipelines release's checks show. The phase is the highest phase those trials registered on ClinicalTrials.gov, not a development stage. Highest phase first, then the most trials.
| Drug | Highest phase registered | Trials | As lead sponsor | Recruiting | Targets | Mechanism | In Drugs and targets | Source |
|---|---|---|---|---|---|---|---|---|
| SEVASEMTEN | Phase 2 | 1 | 0 | 0 | https://conductscience.org/library/drugs/CHEMBL5314486 | Open Targets | ||
| GOLODIRSEN | Phase 1/2 | 1 | 0 | 0 | DMD | Dystrophin pre-mRNA positive modulator | https://conductscience.org/library/drugs/CHEMBL4297762 | Open Targets |
Trials23
The trials that name the company as lead sponsor or collaborator, newest registered first. Results posted are as ClinicalTrials.gov gave them on the day of the sponsors capture.
| Trial | Title | Role | Phase | Status | Type | Participants | Start | Results first posted | Drugs | In Trials | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT07894185 | SMAdult - Monitoring of Movement on Spinal Muscular Atrophy | Collaborator | Not applicable | Recruiting | Interventional | 60 | 2026-07-17 | https://conductscience.org/library/trials/NCT07894185 | ClinicalTrials.gov | ||
| NCT07664124 | Digital Monitoring of Upper Limb Function in Non-Ambulant DMD | Collaborator | Not applicable | Not yet recruiting | Interventional | 50 | 2026-07-30 | https://conductscience.org/library/trials/NCT07664124 | ClinicalTrials.gov | ||
| NCT07389018 | Study to Evaluate the Feasibility of Syde® Digital Endpoints for Monitoring Patients With Progressive Supranuclear Palsy - Richardson Syndrome (PSP-R) | Lead sponsor | Not yet recruiting | Observational | 30 | 2026-05 | https://conductscience.org/library/trials/NCT07389018 | ClinicalTrials.gov | |||
| NCT07388992 | Investigating Specific Gait Patterns in Individuals Living With Multiple Sclerosis | Lead sponsor | Recruiting | Observational | 30 | 2026-03-16 | https://conductscience.org/library/trials/NCT07388992 | ClinicalTrials.gov | |||
| NCT07388966 | Prospective Longitudinal Multicentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia | Lead sponsor | Recruiting | Observational | 140 | 2026-02-06 | https://conductscience.org/library/trials/NCT07388966 | ClinicalTrials.gov | |||
| NCT07286565 | Active NBS Study: Decentralised Monitoring Motor Development in Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified by Newborn Screening | Collaborator | Not applicable | Recruiting | Interventional | 100 | 2025-12-01 | https://conductscience.org/library/trials/NCT07286565 | ClinicalTrials.gov | ||
| NCT07201636 | Natural History Study for Patients With Nemaline Myopathy in Belgium | Collaborator | Not applicable | Not yet recruiting | Interventional | 10 | 2026-08 | https://conductscience.org/library/trials/NCT07201636 | ClinicalTrials.gov | ||
| NCT07136844 | Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology | Collaborator | Not applicable | Recruiting | Interventional | 300 | 2024-03-29 | https://conductscience.org/library/trials/NCT07136844 | ClinicalTrials.gov | ||
| NCT07136506 | Gait Analysis Parameter and Upper Limb Evaluation in Control Participants | Collaborator | Not applicable | Recruiting | Interventional | 200 | 2025-09-24 | https://conductscience.org/library/trials/NCT07136506 | ClinicalTrials.gov | ||
| NCT07031518 | Pilot Study to Identify and Validate Digital Biomarkers in Osteoarthritis of the Knee | Collaborator | Not applicable | Completed | Interventional | 43 | 2025-05-14 | https://conductscience.org/library/trials/NCT07031518 | ClinicalTrials.gov |
1 to 10 of 23
See all 23 trialsConditions34
The conditions its trials name, as the trials write them, with case and spacing folded. The most trials first.
| Condition | Trials |
|---|---|
| Multiple Sclerosis | 4 |
| Amyotrophic Lateral Sclerosis | 2 |
| Duchenne Muscular Dystrophy | 2 |
| Duchenne Muscular Dystrophy (DMD) | 2 |
| Myotonic Dystrophy 1 | 2 |
| Neuromuscular Diseases | 2 |
| Achondroplasia | 1 |
| Angelman Syndrome | 1 |
| Ataxia, Spinocerebellar | 1 |
| Becker Muscular Dystrophy | 1 |
1 to 10 of 34Source ClinicalTrials.gov
See all 34 conditionsPartners17
The other organizations its trials name, as lead sponsor or collaborator, with the class ClinicalTrials.gov gives each. The most trials shared first. A partner that is a company opens its own record.
| Organization | Class | Trials shared | In Companies | Source |
|---|---|---|---|---|
| Centre Hospitalier Universitaire de Liege | Other | 14 | ClinicalTrials.gov | |
| Centre Hospitalier Régional de la Citadelle | Other | 13 | ClinicalTrials.gov | |
| Laurent Servais | Other | 2 | ClinicalTrials.gov | |
| Catholic University of the Sacred Heart | Other | 1 | ClinicalTrials.gov | |
| Consultants for Research in Imaging and Spectroscopy | Other | 1 | ClinicalTrials.gov | |
| Edgewise Therapeutics, Inc. | Industry | 1 | https://conductscience.org/library/companies/edgewise-therapeutics-inc-70dc7b69 | ClinicalTrials.gov |
| Erasme University Hospital | Other | 1 | ClinicalTrials.gov | |
| Great Ormond Street Hospital for Children NHS Foundation Trust | Other | 1 | ClinicalTrials.gov | |
| ImagingNMD | Unknown | 1 | ClinicalTrials.gov | |
| Institut de Myologie, France | Other | 1 | ClinicalTrials.gov |
1 to 10 of 17
See all 17 partnersData dates
The date of each source this release read.
Sources 4
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL
- ClinicalTrials.govNo license stated
- Open TargetsCC0 1.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBLCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this company from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/companies/v1/sysnav-77702043
GET https://conductscience.org/api/companies/v1/sysnav-77702043/trials?page=2